| Wednesday, May 16, 2012 | | | | |
Lab Equipment: Featuring Equipment from Sanofi Aventis and other Leading Global Firms!
Wednesday, May 29-30, 2012
Please click here for more information. | More Top News | Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide cost effective coverage for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. The majority of our clinical staff are MDs or PhDs, including oncologists in strategic areas for clinical trials. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.
Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK +44-0-1344 891121. | | More Featured News | BioContact Quebec October 3-4, 2012 Chateau Laurier Quebec 1220 Place
Biopharmaceutical partnership symposium that is expecting more than 500 participants representing all sectors of the industry. namely biopharmaceutical and pharmaceutical companies, universities, venture capital, consulting and governmental organizations.
For more information, please visit: www.biocontact.ca. | | • Multiple Regions (SF, LA, Cleveland, NYC)
Corcept Therapeutics Medical Science Liaison Conduct one-on-one healthcare professional education. Provide pro-active support of Corcept products related to education, and appropriate communication triaging of TLs, and the core patient support services.
• Pharm Country (Bedminster, New Jersey)
Allergan Inc. Senior Statisticial Programmer - Systems Development Will provide specialized knowledge and support to carry out systems development activities in support of one or more clinical research studies. Providing leadership and/or support for creating and maintaining systems used to analyze and report trials data.
• Genetown (Lexington, Massachusetts)
Shire Principal Scientist - Late Stage Formulation Will lead a group of scientists and engineers involved in late stage pharmaceutical development of Shire HGT's products. The scope of the work includes formulation development and support of late phase clinical and commercial manufacturing processes.
• Rocky Bio (Tucson, Arizona)
Ventana Medical Systems, Inc. Director, Regulatory Affairs Responsible for leading the day-to-day activities of Regulatory Affairs with specific emphasis on global regulatory submission strategy, regulatory submissions, and interaction with global regulatory authorities related to companion diagnostic projects.
• Biotech Bay (Sunnyvale, California)
Pharmacyclics, Inc. Senior Manager, GCP Quality Assurance Will play an essential role in the company's GCP QA program focused conducting internal and external GCP audits to ensure the clinical trials are conducted in accordance with GCP regulations and ICH guidelines.
Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! | |
Biotech Bay Career Fair
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area.
Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.
Job seekers may register here.
• Biotech Bay Career Fair, Burlingame, CA May 29, 2012
More information about BioSpace's Career Fairs
BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services | | Advances in Ion Channel Drug Discovery
• Understand the competitive landscape in ion channel modulation and compare the pipelines of specialist companies operating in this area • Identify the most promising targets from a "likelihood of success" viewpoint. • Identify the targets with scope for ion channel intervention and major market opportunity.
Click Here for More Information. |
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing
This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.
Request Now! | Nektar Therapeutics (CA) Corporate Headquarters 455 Mission Bay Boulevard South San Francisco, California 94158 U.S.A. Phone: 415-482-5300 Fax: 415-339-5300
Nektar Therapeutics (Nektar) is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
More Company Profiles | | | FREE Subscription to Microwave Product Digest
Microwave Product Digest is the premier new product magazine devoted to information on components, equipment and subsystems for the RF, microwave and wireless industries. |
| Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship
BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 | BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 | Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong
BioSpace.com - Life. Science. Community. | | • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. | | | | | | |
No comments:
Post a Comment